Gentian Diagnostics : Cystatin C at IFCC EuroMedLab in Munich 2022
April 04, 2022 at 07:54 am
Share
Learn more about cystatin C at booth #201
Gentian Diagnostics looks forward to exhibit at IFCC EuroMedLab in Munich April 2022 promoting our turbidimetric cystatin C immunoassay. Visit us at booth #201 to learn more about cystatin C.
Cystatin C - A superior kidney marker1
Unique prognostic and diagnostic value of cystatin C:
independent of muscle mass2-8
estimates GFR without race-adjustment9
correlates well with GFR within the "creatinine blind area"10
identifies chronic kidney disease (CKD) earlier than creatinine-based eGFR11
ensures safety and efficacy of medications with a narrow therapeutic index9,12
Visit us at our booth #201 to learn more about cystatin C
Visit us during opening hours or book a meeting in advance through marketing@gentian.com.
Gentian Cystatin C Immunoassay
Gentian's cystatin C immunoassay was launched in 2006. The assay is FDA510(k) cleared since 2008 and CE-marked. It is a Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro testing of cystatin C in human plasma and serum samples. The test has documented high inter-instrument accuracy on a wide range of clinical chemistry analysers.
Assay highlights
Particle-Enhanced Turbidimetric Immunoassay
With avian antibodies for reduced interference
Can be applied on most automated platforms
ERM-DA471/IFCC standardised
FDA510 (k) cleared and CE-marked
Contact us
If you and your colleagues would like to learn more about cystatin C and how you could incorporate this test into clinical workflows within your organisation, please contact us via marketing@gentian.com or the form below:
References:
Dharnidharka VR et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002
1-226.KDIGO Guidelines 2012 published in Kidney International Supplements Vol3 Issue 1, Jan 2013
NCIC Clinical guideline (CG182) updated jan 2015 section 2.1 https://www.nice.org.uk/guidance/cg182/chapter/2-Implementation-getting-started.
Tangri N et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int. 2011
Grubb A. Cystatin C is Indispensable for Evaluation of Kidney Disease. EJIFCC. 2017
Björk J et al. Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children. Pediatr Nephrol. 2019
Inker LA et al. Estimating glomerular filtration rate from serum creatinine and cystatin C[published correction appears in N Engl J Med. 2012
Schaeffner ES et al. Two novel equations to estimate kidney function in persons aged 70 years or older.Ann Intern Med. 2012
Ebert N, Shlipak MG. Cystatin C is ready for clinical use. Curr Opin Nephrol Hypertens. 2020
Lindström V. Low molecular mass proteins as markers for renal function and dialysis efficiency. Doctoral Dissertation, Lund University, 2013.
Murty MS et al. Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol. 2013
Frazee E et al. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project. Am J Kidney Dis. 201
Attachments
Original Link
Original Document
Permalink
Disclaimer
Gentian Diagnostics AS published this content on 04 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 April 2022 06:53:09 UTC.
Gentian Diagnostics ASA is a Norway-based company within health care sector. The Company develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Companyâs product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The Company is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.